Videos

Our panel of doctors and pharmacists introduce naloxone, an opioid antagonist, as an option when treating opioid abuse or overdose.

The panel explains the common challenges they find when trying to treat a patient with opioids.

Experts in sleep disorders provide clinical practice pearls and takehome messages for the management of insomnia.

Disorders and COVID-19

By

Michael J Thorpy, M.B., Ch.B and Karl Doghramji, MD discuss the impact of COVID-19 on sleep disorders and depression.

Q&A

This expert panel fields multidisciplinary questions on maskne, compliance, access to care and more.

What’s New?

Acne patients are benefitting from a robust pipeline with treatments that hold promise for increased efficacy and safety. First-in-class additions to the FDA-approved armamentarium, such as the novel antiandrogen clascoterone (Winlevi; Sun Pharma), give dermatologists and pediatricians new tools to combat this skin condition. Speakers offer insights on matching medications to individual patient needs and controlling costs.